脊髓损伤
移植
他克莫司
医学
再生(生物学)
蛋白激酶B
粒体自噬
PI3K/AKT/mTOR通路
脊髓
神经科学
生物
细胞生物学
信号转导
外科
自噬
细胞凋亡
生物化学
作者
Zhenming Tian,Han‐Jian Hu,Carmen Chan,Tian Hu,Chaoyang Cai,Hong Li,Limin Rong,Gang‐Biao Jiang,Bin Liu
标识
DOI:10.1002/advs.202407757
摘要
Abstract In the realm of neural regeneration post‐spinal cord injury, hydrogel scaffolds carrying induced neural stem cells (iNSCs) have demonstrated significant potential. However, challenges such as graft rejection and dysfunction caused by mitochondrial damage persist after transplantation, presenting formidable barriers. Tacrolimus, known for its dual role as an immunosuppressant and promoter of neural regeneration, holds the potential for enhancing iNSC transplantation. However, systemic administration of tacrolimus often comes with severe side effects. This study pioneers the development of a self‐healing hydrogel with sustained‐release tacrolimus (COCu‐Tac), tailored specifically for iNSC transplantation after spinal cord injury. This research reveals that the sustained release of tacrolimus enhances axonal growth and improves mitochondrial quality control in iNSCs and neurons. Further analysis shows that tacrolimus targets FKBP52 rather than FKBP51, enhancing mitophagy via the FKBP52/AKT pathway. This advanced system demonstrates significant efficacy in promoting neural regeneration and restoring motor function following spinal cord injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI